Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Stock Short Interest Report for October

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) was the recipient of a significant decrease in short interest during the month of October. As of October 15th, there was short interest totaling 1,699 shares, a decrease of 76.4% from the September 30th total of 7,209 shares. Based on an average trading volume of 8,969 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.1% of the shares of the stock are sold short.

Institutional Investors Weigh In On Fidelity Disruptive Medicine ETF

A hedge fund recently bought a new position in Fidelity Disruptive Medicine ETF stock. Root Financial Partners LLC bought a new position in Fidelity Disruptive Medicine ETF (NASDAQ:FMED) in the third quarter, according to the company in its most recent filing with the SEC. The fund bought 1,291 shares of the company’s stock, valued at approximately $42,000. Root Financial Partners LLC owned 0.08% of Fidelity Disruptive Medicine ETF as of its most recent filing with the SEC.

Fidelity Disruptive Medicine ETF Price Performance

Shares of FMED stock traded down $1.09 during trading hours on Friday, hitting $32.36. The stock had a trading volume of 3,030 shares, compared to its average volume of 10,600. The stock has a market capitalization of $51.78 million, a price-to-earnings ratio of 41.33 and a beta of 0.76. The stock’s 50-day moving average price is $31.76 and its two-hundred day moving average price is $27.78. Fidelity Disruptive Medicine ETF has a one year low of $23.48 and a one year high of $33.56.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.